NXST is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants a clear entry now. The stock has supportive analyst sentiment and a favorable strategic thesis around the Tegna deal, but the current chart is still technically weak, insider selling is increasing, and there is no AI Stock Picker or SwingMax buy signal today. My direct view: hold off for now rather than buy immediately.
The technical setup is bearish to weak. MACD histogram is negative at -0.875 and still contracting, which suggests downside momentum remains in place. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, confirming a broader downtrend. RSI_6 at 25.756 is deeply oversold, but it is labeled neutral here and does not yet confirm a reversal. Price at 186 is just above S1 support at 184.421 and below the pivot at 192.848, so the stock is trading near support but has not reclaimed trend strength. The nearby resistance levels are 201.275 and 206.481.

Analysts remain broadly constructive on the Tegna transaction story. Citi upgraded NXST to Buy with a $220 target, saying the Street may be too bearish and framing the setup as favorable on a risk-reward basis. Benchmark, Deutsche Bank, and Barrington all maintain positive ratings and see value creation from the Tegna acquisition, scale benefits, and stronger distribution revenue. The news around TEGNA appointing former Fox TV executive Patrick Paolini as CEO may help operational execution during merger-related uncertainty. The stock trend model also suggests a positive short-term bounce probability.
The Tegna merger is still facing legal and regulatory friction, including a court order blocking the merger, which keeps uncertainty high. Insider selling has increased 245.84% over the last month, which is a negative confidence signal. Hedge funds are neutral with no notable buying trend. Technically, the stock remains in a downtrend and has not confirmed a reversal. There is no AI Stock Picker signal and no recent SwingMax entry, so the proprietary signals do not support aggressive buying today.
No financial snapshot was available, so latest-quarter revenue, EPS, and growth trends cannot be directly assessed from the provided data. Because the latest quarter season is not included in the financial data, there is no reliable quarter-by-quarter financial read here.
Wall Street is still generally positive, but the tone has become more mixed and valuation targets are coming down. Citi upgraded NXST to Buy with a $220 target, though that is below its prior $252 target, showing optimism tempered by caution. Benchmark cut its target to $250 from $300 but kept Buy. Deutsche Bank raised its target to $270 and Barrington to $290, both maintaining bullish views tied to strategic value from Tegna. The pros see scale, distribution revenue growth, and potential merger synergies; the cons are legal overhang, merger complexity, and recent target cuts, which suggest conviction is positive but less aggressive than before.